MedPath

Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia

Not Applicable
Completed
Conditions
Headache
Aura
Migraine
Interventions
Other: Hypoxia
Other: Placebo
Registration Number
NCT01896167
Lead Sponsor
Danish Headache Center
Brief Summary

In this study the investigators will investigate the following hypothesis

* that hypoxia induce migraine headache and migraine aura

* the aura phase is associated with a spreading reduction in cerebral blood flow

* the migraine headache is associated with dilatation of intra- and extracerebral arteries

* the migraine headache is associated with changes in brain metabolism

* the pre-ictal stage of a migraine attack with aura is associated with specific patterns in neural activity.

Detailed Description

To investigate migraine with aura symptoms during and after hypoxia.

With magnetic resonance imaging the investigators will investigate changes in

* regional cerebral blood flow (rCBF)

* resting state functional connectivity

* circumference of the middle cerebral artery(MCA), internal carotic artery, superficial temporal artery, medial meningeal artery, external carotic artery

* brain metabolism

And compare these changes with a aged match healthy control group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria

Migraine with aura patients and Helthy volunteers as controls:

  • Aged 18-40
  • 50-100 kg
Exclusion Criteria
  • Tension type headache more than 5 days/month
  • Other primary headaches
  • Daily medication except contraceptives
  • Drug taken within 4 times the halflife for the specific drug except contraceptives
  • Pregnant or lactating women
  • Headache or migraine attack within the last 48 hours before start of trial
  • Hypertension
  • Hypotension
  • Respiratory or cardiac disease
  • smoking

Extra exclusion Criteria for healthy volunteers:

  • migraine at present or earlier in life
  • parents, sibling or children who suffer or have suffered from migraine

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
HypoxiaHypoxiaInhalation of air with 8-12% oxygen content
Atmospheric airPlaceboInhalation of atmospheric air, with oxygen content at 21%
Primary Outcome Measures
NameTimeMethod
Headache and aura24 h

Comparison between hypoxia and placebo (atmospheric air)

Secondary Outcome Measures
NameTimeMethod
BOLD response in visual cortexBaseline, 170 min and 220 min

Hypoxia induced changes in BOLD response

Brain metabolismBaseline, 180 min and 230 min post hypoxia

Hypoxia induced changes in brain metabolism

artery circumferenceBaseline, 120 and 200 min

Hypoxia induced changes in intra- and extracranial circumference

Cerebral blood flowBaseline, 120 and 200 min

Hypoxia induced changes in cerebral blood flow

Trial Locations

Locations (1)

Nanna Arngrim

🇩🇰

Glostrup, Denmark

© Copyright 2025. All Rights Reserved by MedPath